Construction and Effect Evaluation of Malignant Fungating Wounds Care Regimen for Breast Cancer Patients
Malignant Fungating Wound
About this trial
This is an interventional treatment trial for Malignant Fungating Wound focused on measuring Breast cancer, Malignant fungating wounds, Symptom management, Wound care, Quality of life
Eligibility Criteria
Inclusion Criteria:
Age greater than or equal to 18 years old with pathologically confirmed diagnosis of breast cancer.
Tumor metastasis in the chest wall or other sites and rupture to form a malignant fungating wound with a wound area of at least 10cm2 or more.
Knowing of the cancer diagnosis. ④ Capable and willing to receive follow-up.
- Informed consent and voluntary participation.
Exclusion Criteria:
Patients with mental illness or cognitive impairment and language expression deficiency.
Patients with extensive metastasis of cancer throughout the body to the chest, shoulders, back, arms, etc. and whose treatment was ineffective.
Patients at the end stage of death.
- Patients who refused to participate in this study.
Withdrawal criteria:
Patients who developed serious complications during the study and were unable to continue the study.
- Patients who died during the study. ③Patients who requested withdrawal on their own during the study.
Sites / Locations
- Sun Yat-sen memorial hospital, Sun Yat-sen universityRecruiting
Arms of the Study
Arm 1
Experimental
malignant fungating wounds care regimen
malignant fungating wounds care regimen based on the evidences, expert consultation, pre-experiment and final determination